Evidence map›Paper›PMID 38621141›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.

Yuta Okabe, Nobuyuki Murakoshi, Nagomi Kurebayashi, Hana Inoue, Yoko Ito, Takashi Murayama, Chika Miyoshi, Hiromasa Funato, Koichiro Ishii, Dongzhu Xu and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Yuta OkabeDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Nobuyuki MurakoshiDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Nagomi KurebayashiDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-5005-9698
Hana InoueDepartment of Physiology, Tokyo Medical University, Tokyo 160-8402, Japan.ORCID 0000-0002-2278-5617
Yoko ItoDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Takashi MurayamaDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-3845-2980
Chika MiyoshiInternational Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Hiromasa FunatoInternational Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.ORCID 0000-0002-2787-9700
Koichiro IshiiDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Dongzhu XuDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Kazuko TajiriDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Rujie QinDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Kazuhiro AonumaDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Yoshiko MurakataDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Zonghu SongDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Shigeharu WakanaTechnology and Development Team for Mouse Phenotype Analysis, RIKEN BioResource Center, Tsukuba 305-0074, Japan.
Utako YokoyamaDepartment of Physiology, Tokyo Medical University, Tokyo 160-8402, Japan.
Takashi SakuraiDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Kazutaka AonumaDepartment of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Masaki IedaDepartment of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Masashi YanagisawaInternational Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.ORCID 0000-0002-7358-4022
University of Tsukuba · JPJuntendo University · JPUniversity of Wisconsin–Madison · US

Funding

Japan Agency for Medical Research and Development (AMED) JP21am0101080Japan Agency for Medical Research and Development (AMED) JP21zf0127005MEXT | Japan Society for the Promotion of Science (JSPS) 16H05045MEXT | Japan Society for the Promotion of Science (JSPS) 17H06095 and 22H04918MEXT | Japan Society for the Promotion of Science (JSPS) 19H03404MEXT | Japan Society for the Promotion of Science (JSPS) 23659410MEXT | Japan Society for the Promotion of Science (JSPS) 9K07105MEXT | Japan Society for the Promotion of Science (JSPS) FIRSTMEXT | Japan Society for the Promotion of Science (JSPS) WPIVehicle Racing Commemorative Foundation 6237
6 · The paper itself

Abstract

Inherited arrhythmia syndromes (IASs) can cause life-threatening arrhythmias and are responsible for a significant proportion of sudden cardiac deaths (SCDs). Despite progress in the development of devices to prevent SCDs, the precise molecular mechanisms that induce detrimental arrhythmias remain to be fully investigated, and more effective therapies are desirable. In the present study, we screened a large-scale randomly mutagenized mouse library by electrocardiography to establish a disease model of IASs and consequently found one pedigree that exhibited spontaneous ventricular arrhythmias (VAs) followed by SCD within 1 y after birth. Genetic analysis successfully revealed a missense mutation (p.I4093V) of the ryanodine receptor 2 gene to be a cause of the arrhythmia. We found an age-related increase in arrhythmia frequency accompanied by cardiomegaly and decreased ventricular contractility in the

Indexed as

Tachycardia, VentricularAnimalsArrhythmias, CardiacDeath, Sudden, CardiacFlecainideMiceMutationMutation, MissenseRyanodine Receptor Calcium Release ChannelFlecainideRyanodine Receptor Calcium Release Channelanimal modelcatecholaminergic polymorphic ventricular tachycardiaforward geneticsinherited arrhythmia syndromeryanodine receptor 2

Identifiers

PMID38621141
PMCPMC11047072
OpenAlexW4394822543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.